Pfizer (PFE) announces a deal worth up to $725M to develop and commercialize Medivation's (MDVN)...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) announces a deal worth up to $725M to develop and commercialize Medivation's (MDVN) Alzheimer's drug. Pfizer is trying to expand its product pipeline before blockbuster Lipitor loses its patent protection. Pre-market: MDVN +28%.